P53 and the defenses against genome instability caused by transposons and repetitive elements
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
The recent publication by Wylie et al. is reviewed, demonstrating that the p53 protein regulates the movement of transposons. While this work presents genetic evidence for a piRNA‐mediated p53 interaction with transposons in Drosophila and zebrafish, it is herein placed in the context of a decade or so of additional work that demonstrated a role for p53 in regulating transposons and other repetitive elements. The line of thought in those studies began with the observation that transposons damage DNA and p53 regulates DNA damage. The presence of transposon movement can increase the rate of evolution in the germ line and alter genes involved in signal transduction pathways. Transposition can also play an important role in cancers where the p53 gene function is often mutated. This is particularly interesting as recent work has shown that de‐repression of repetitive elements in cancer has important consequences for the immune system and tumor microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular and genetic properties of tumors associated with local immune cytolytic activity
Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G., & Hacohen, N. (2015) · Cell · doi:10.1016/j.cell.2014.12.033 · Cited by 3,825 · cited 1×
“Similarly, results indicating that HERV expression, can initiate the innate immune response in a variety of malignancies leading to alterations in the local tumor microenvironment that can affect the response to immunotherapies [48–50].”
ResultChiappinelli, K. B., Strissel, P. L., Desrichard, A., Li, H., Henke, C., Akman, B., Hein, A., Rote, N. S., Cope, L. M., Snyder, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.011 · Cited by 2,022
Roulois, D., Loo Yau, H., Singhania, R., Wang, Y., Danesh, A., Shen, S. Y., Han, H., Liang, G., Jones, P. A., Pugh, T. J., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.056 · Cited by 1,527
The Piwi-piRNA Pathway Provides an Adaptive Defense in the Transposon Arms Race
Aravin, A. A., Hannon, G. J., & Brennecke, J. (2007) · Science · doi:10.1126/science.1146484 · Cited by 1,096
Hot L1s account for the bulk of retrotransposition in the human population
Brouha, B., Schustak, J., Badge, R. M., Lutz-Prigge, S., Farley, A. H., Moran, J. V., & Kazazian, H. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0831042100 · Cited by 1,073
Landscape of Somatic Retrotransposition in Human Cancers
Lee, E., Iskow, R., Yang, L., Gokcumen, O., Haseley, P., Luquette, L. J., Lohr, J. G., Harris, C. C., Ding, L., Wilson, R. K., et al. (2012) · Science · doi:10.1126/science.1222077 · Cited by 762 · cited 1×
“In addition to these effects on the innate immune system, the expression of repetitive elements in cancer can drive genomic instability through retrotransposon insertional mutagenesis [51–53] as well as chromosomal instability driven by satellite repeat expression [54, 55].”
BackgroundLoss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation
Jackson-Grusby, L., Beard, C., Possemato, R., Tudor, M., Fambrough, D., Csankovszki, G., Dausman, J., Lee, P., Wilson, C., Lander, E., et al. (2001) · Nature Genetics · doi:10.1038/83730 · Cited by 694
Somatic retrotransposition alters the genetic landscape of the human brain
Baillie, J. K., Barnett, M. W., Upton, K. R., Gerhardt, D. J., Richmond, T. A., De Sapio, F., Brennan, P. M., Rizzu, P., Smith, S., Fell, M., et al. (2011) · Nature · doi:10.1038/nature10531 · Cited by 684
LINE-1 Retrotransposition Activity in Human Genomes
Beck, C. R., Collier, P., Macfarlane, C., Malig, M., Kidd, J. M., Eichler, E. E., Badge, R. M., & Moran, J. V. (2010) · Cell · doi:10.1016/j.cell.2010.05.021 · Cited by 632
Natural mutagenesis of human genomes by endogenous retrotransposons
Iskow, R. C., McCabe, M. T., Mills, R. E., Torene, S., Pittard, W. S., Neuwald, A. F., Van Meir, E. G., Vertino, P. M., & Devine, S. E. (2010) · Cell · doi:10.1016/j.cell.2010.05.020 · Cited by 551
Cited by
Kastenhuber, E. R., & Lowe, S. W. (2017) · Cell · doi:10.1016/j.cell.2017.08.028 · Cited by 1,906
Dunphy, G., Flannery, S. M., Almine, J. F., Connolly, D. J., Paulus, C., Jønsson, K. L., Jakobsen, M. R., Nevels, M. M., Bowie, A. G., & Unterholzner, L. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.034 · Cited by 648
“A role for DNA damage factors and particularly p53 in anti-viral defense and innate immunity has been proposed, because p53 is responsive to type I interferons, can act as a restriction factor for viruses and transposons, and is in turn targeted by multiple viral evasion mechanisms (Levine et al., 2016; Miciak and Bun…”
BackgroundADAR1: “Editor-in-Chief” of Cytoplasmic Innate Immunity
Lamers, M. M., van den Hoogen, B. G., & Haagmans, B. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01763 · Cited by 229
Deciphering p53 signaling in tumor suppression
Mello, S. S., & Attardi, L. D. (2018) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.11.005 · Cited by 206
“Current Opinion in Cell Biology 2018, 51:65–72 suggested that p53 preserves genomic integrity by restricting the movement of transposons and repetitive elements, which might reflect an evolutionary function of p53 [16 ,17].”
BackgroundTranslating p53-based therapies for cancer into the clinic
Peuget, S., Zhou, X., & Selivanova, G. (2024) · Nature Reviews Cancer · doi:10.1038/s41568-023-00658-3 · Cited by 190
Pan-cancer analysis identifies tumor-specific antigens derived from transposable elements
Shah, N. M., Jang, H. J., Liang, Y., Maeng, J. H., Tzeng, S.-C., Wu, A., Basri, N. L., Qu, X., Fan, C., Li, A., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01349-3 · Cited by 175
Zhou, X., Singh, M., Sanz Santos, G., Guerlavais, V., Carvajal, L. A., Aivado, M., Zhan, Y., Oliveira, M. M. S., Westerberg, L. S., Annis, D. A., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1741 · Cited by 169
The many faces of p53: something for everyone
Levine, A. J. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz026 · Cited by 163
“ity is lost, and these elements are activated and create a genomic instability (Levine et al., 2016).”
BackgroundSelf-citationP53 and The Immune Response: 40 Years of Exploration—A Plan for the Future
Levine, A. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020541 · Cited by 97
“P53 is not the only check upon silencing repetitive elements in a cell [30], but it is an important one in cancer cells.”
BackgroundInfluentialSelf-citationReverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer.
Rajurkar, M., Parikh, A. R., Solovyov, A., You, E., Kulkarni, A. S., Chu, C., Xu, K. H., Jaicks, C., Taylor, M. S., Wu, C., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1117 · Cited by 61
“Overall, these findings in colorectal cancer are consistent with other models demonstrating a direct role of p53 in regulating repeat RNAs (24, 28), which would indicate p53 mutation is a potential genetic marker of colorectal cancer tumors sensitive to 3TC.”
Self-citationp53 in the game of transposons
Wylie, A., Jones, A. E., & Abrams, J. M. (2016) · BioEssays · doi:10.1002/bies.201600115 · Cited by 29
Nogalski, M. T., & Shenk, T. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2017734117 · Cited by 25
“Satellite DNAs (satDNAs), which account for ∼3% of the genome (1), are constituents of centromeric and pericentromeric heterochromatin, and have been implicated in chromosome organization and segregation, kinetochore formation, as well as heterochromatin regulation (2).”
BackgroundDumetier, B., Sauter, C., Hajmirza, A., Pernon, B., Aucagne, R., Fournier, C., Row, C., Guidez, F., Rossi, C., Lepage, C., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10123101 · Cited by 9
“It is also of note that p53 and BRCA tumor suppressor proteins function in repeat element silencing [15,16], as does pRB/EZH2 [17] and the transcription factor PLZF [18].”
Background
Metadata
- Authors
- Levine, A. J., Ting, D. T., & Greenbaum, B. D.
- Venue
- BioEssays
- Publisher
- Wiley
- Published
- 2016-05-13
- Volume
- 38
- Issue
- 6
- Pages
- 508-513
- ISSN
- 0265-9247 (ISSN-L)
- 1521-1878
- OpenAlex
- W2385363635
- Cited by
- 72
- References
- 19
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.